Linomide Blocks Angiogenesis in Breast Cancer
Author Information
Author(s): M Ziche, S Donnini, L Morbidelli, A Parenti, G Gasparini, F Ledda
Primary Institution: Department of Pharmacology, University of Florence
Hypothesis
Can linomide effectively block angiogenesis induced by breast carcinoma cells?
Conclusion
Linomide can efficiently and persistently block VEGF-dependent angiogenesis in vivo in the absence of a growing tumor mass.
Supporting Evidence
- Linomide treatment blocked angiogenesis within 48 hours.
- The antiangiogenic effect lasted over 10 days after treatment suspension.
- Linomide did not show cytotoxic effects on resting capillary endothelial cells.
Takeaway
Linomide is a drug that helps stop the growth of new blood vessels in breast cancer, which can help prevent the cancer from spreading.
Methodology
The study used a rabbit cornea model to assess the effect of linomide on angiogenesis induced by breast carcinoma cells.
Limitations
The study was conducted in a rabbit model, which may not fully replicate human responses.
Participant Demographics
Female New Zealand white rabbits (2.5-3 kg) were used in the study.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website